These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 212188)

  • 21. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.
    Radinsky R; Flickinger KS; Kosir MA; Zardi L; Culp LA
    Cancer Res; 1990 Jul; 50(14):4388-400. PubMed ID: 2163749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrese of collagen biosynthesis ability of Swiss 3T3 cells transformed with the murine sarcoma virus (MSV).
    Bańkowski E; Galewska Z; Domaniak A; Rzeczycki W
    Bull Acad Pol Sci Biol; 1979; 27(5):345-8. PubMed ID: 232424
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of rous sarcoma virus transformation of rat-1 fibroblasts upon their growth factor and anchorage requirements in serum-free medium.
    Giguère L; Gospodarowicz D
    Cancer Res; 1983 May; 43(5):2121-30. PubMed ID: 6299541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell-line produce transforming factors.
    Ozanne B; Fulton RJ; Kaplan PL
    J Cell Physiol; 1980 Oct; 105(1):163-80. PubMed ID: 6253509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of infection with Moloney sarcoma and leukemia viruses on nucleic acid synthesis in mouse cell cultures.
    Hirschman SZ; Fischinger PJ; O'Connor TE
    J Natl Cancer Inst; 1970 Jan; 44(1):107-16. PubMed ID: 11515020
    [No Abstract]   [Full Text] [Related]  

  • 26. Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors.
    De Larco JE; Todaro GJ
    J Cell Physiol; 1980 Feb; 102(2):267-77. PubMed ID: 6246130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in the characteristics of sugar uptake by mouse cells transformed by murine sarcoma viruses.
    Hatanaka M; Huebner RJ; Gilden RV
    J Natl Cancer Inst; 1969 Nov; 43(5):1091-6. PubMed ID: 4312003
    [No Abstract]   [Full Text] [Related]  

  • 28. Transforming growth factors (TGFs): properties and possible mechanisms of action.
    Todaro GJ; De Larco JE; Fryling C; Johnson PA; Sporn MB
    J Supramol Struct Cell Biochem; 1981; 15(3):287-301. PubMed ID: 6267317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F.
    Pircher R; Lawrence DA; Jullien P
    Cancer Res; 1984 Dec; 44(12 Pt 1):5538-43. PubMed ID: 6093998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of tumorigenic and metastatic properties of murine sarcoma virus-transformed nonproducer Balb/3T3 cell lines.
    Yogeeswaran G; Stein BS; Sebastian H
    J Natl Cancer Inst; 1980 Apr; 64(4):951-7. PubMed ID: 6245299
    [No Abstract]   [Full Text] [Related]  

  • 31. Modulation by normal serum factors of Kirsten murine sarcoma virus-induced transformation in adult rat cells infected in early passage.
    Auersperg N; Siemens CH; Krystal G; Myrdal SE
    Cancer Res; 1986 Nov; 46(11):5715-23. PubMed ID: 3019533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Block in the expression of differentiation markers of rat thyroid epithelial cells by transformation with Kirsten murine sarcoma virus.
    Fusco A; Pinto A; Tramontano D; Tajana G; Vecchio G; Tsuchida N
    Cancer Res; 1982 Feb; 42(2):618-26. PubMed ID: 6275984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-derived growth factor (PDGF) enhances the growth of Moloney sarcoma virus-induced tumors in mice.
    Inglot AD; Inglot O
    Arch Immunol Ther Exp (Warsz); 1981; 29(4):431-7. PubMed ID: 7332446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of interferons inhibitory effect on cell growth by the mitogenic stimulus.
    Taylor-Papadimitriou J; Rozengurt E
    Tex Rep Biol Med; 1981-1982; 41():509-16. PubMed ID: 6189216
    [No Abstract]   [Full Text] [Related]  

  • 35. Phenotypically distinct target cells for murine sarcoma virus and murine leukemia virus marrow transformation in vitro.
    Greenberger JS
    J Natl Cancer Inst; 1979 Feb; 62(2):337-48. PubMed ID: 216835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcoma growth factor and other transforming peptides produced by human cells: interactions with membrane receptors.
    Todaro GJ; De Larco JE; Fryling CM
    Fed Proc; 1982 Nov; 41(13):2996-3003. PubMed ID: 6292003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factors released from Kirsten sarcoma virus transformed cells do not compete for epidermal growth factor membrane receptors.
    Chua CC; Geiman D; Ladda RL
    J Cell Physiol; 1983 Oct; 117(1):116-22. PubMed ID: 6311845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmented immunogenicity of tumor cell membranes produced by infection with influenza virus as compared to Moloney sarcoma virus.
    Takeichi N; Austin FC; Oikawa T; Boone CW
    Cancer Res; 1978 Dec; 38(12):4580-4. PubMed ID: 214226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.
    Yron I; Wood TA; Spiess PJ; Rosenberg SA
    J Immunol; 1980 Jul; 125(1):238-45. PubMed ID: 6966652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticosteroids and RNA tumor viruses.
    Paran M; Wu AM; Richardson LS; Gallo RC
    Hamatol Bluttransfus; 1974; 14():197-205. PubMed ID: 4141322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.